Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
abrdn Healthcare Investors's earnings per share without non-recurring items for the
six
months ended in Mar. 2026 was $1.38.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $4.47.
During the past 12 months, abrdn Healthcare Investors's average earnings per share (NRI) Growth Rate was 3338.50% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for abrdn Healthcare Investors's EPS without NRI or its related term are showing as below:
During the past 9 years, abrdn Healthcare Investors's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 31.60% per year. The lowest was -41.50% per year. And the median was 0.40% per year.
HQH's 3-Year EPS without NRI Growth Rate is not ranked *
in the Asset Management industry.
Industry Median: 13 * Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
abrdn Healthcare Investors (NYSE:HQH) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
abrdn Healthcare Investors EPS without NRI Related Terms
abrdn Healthcare Investors EPS without NRI Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Asset Management subindustry, abrdn Healthcare Investors's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
abrdn Healthcare Investors PE Ratio without NRI vs Asset Management Industry
For the Asset Management industry and Financial Services sector, abrdn Healthcare Investors's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where abrdn Healthcare Investors's PE Ratio without NRI falls into.
abrdn Healthcare Investors EPS without NRI Calculation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $4.47
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
abrdn Healthcare Investors (HQH) has a EPS without NRI of $4.47 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on abrdn Healthcare Investors and its competitors. According to the industry distribution chart, abrdn Healthcare Investors ranks #999999 out of 831 companies in the Asset Management industry.
Is abrdn Healthcare Investors' EPS without NRI too high?
abrdn Healthcare Investors' current EPS without NRI is $4.47. The Asset Management industry median EPS without NRI is 13.00. abrdn Healthcare Investors' value of $4.47 is 65.6% below this industry median. Based on the distribution chart, abrdn Healthcare Investors ranks #999999 out of 831 companies in the Asset Management industry, which is in the bottom quartile relative to peers. Overall, abrdn Healthcare Investors has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does abrdn Healthcare Investors' EPS without NRI compare to DSL and NMZ?
According to the Asset Management industry distribution chart, abrdn Healthcare Investors ranks #999999 out of 831 companies for EPS without NRI. This places abrdn Healthcare Investors in the lower half of its industry. The industry median EPS without NRI is 13.00. abrdn Healthcare Investors' value of $4.47 is 65.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for an Asset Management company?
The median EPS without NRI among Asset Management companies is 13.00, based on 831 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. abrdn Healthcare Investors's current EPS without NRI of $4.47 is 65.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on abrdn Healthcare Investors and its competitors. For the Asset Management industry, the median EPS without NRI is 13.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. abrdn Healthcare Investors's current EPS without NRI is $4.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is abrdn Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, abrdn Healthcare Investors (HQH) is currently considered Possible Value Trap. The stock's GF Value™ is $50.26, compared to a current price of $20.88 — trading 58.5% below its estimated fair value. The current EPS without NRI is $4.47 and 65.6% below the Asset Management industry median of 13.00. abrdn Healthcare Investors' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For abrdn Healthcare Investors (HQH), the current EPS without NRI is $4.47 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is abrdn Healthcare Investors (HQH) Overvalued in 2026?
Based on GuruFocus' analysis, abrdn Healthcare Investors stock appears to be undervalued.
The current stock price of $20.88 is trading 58.5% below its estimated GF Value™ of $50.26.
GuruFocus considers abrdn Healthcare Investors to be Possible Value Trap.
Key valuation signals for HQH:
EPS without NRI: $4.47
GF Value™: $50.26 vs. price of $20.88 (58.5% below fair value)
Industry Position: 65.6% below the Asset Management median (#999999 of 831)
No single metric tells the full story. See the HQH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.
49GF Score
Get the complete analysis for HQH
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HQH has been successfully added to your 
